Skip to content

Clinical trials

Thromboembolism trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thromboembolism Clear all

288 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20013
20027
20039
20048
20057
200620
200713
20089
200912
20107
20119
20128
20139
201415
201512
201612
201710
20187
201914
202019
202113
202212
202311
202412
20259
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed181
Unknown status40
Recruiting25
Terminated20
Not yet recruiting7
Withdrawn6
Active, not recruiting6
Enrolling by invitation3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer15
Boehringer Ingelheim12
GlaxoSmithKline9
Astellas Pharma Inc4
Daiichi Sankyo Co., Ltd.4
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)3
Beijing Chao Yang Hospital3
Brigham and Women's Hospital3
Hamilton Health Sciences Corporation3
Inari Medical3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thromboembolism288
Thrombosis48
Venous Thromboembolism43
Atrial Fibrillation39
Venous Thrombosis34
Pulmonary Embolism32
Hemorrhage31
Stroke25
Cardiovascular Diseases17
COVID-1915

Trials

Showing 51 to 75 of 288. Each trial links to its page on Pharma Observatory.

188 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.